| Overview |
| bsm-51051M |
| LXN (9C2) Monoclonal Antibody |
| WB |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Mouse |
| This LXN monoclonal antibody is generated from mouse immunized with LXN recombinant protein. |
| Monoclonal |
| #REF! |
| IgG1 |
| 0.5ug/ul |
| Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C for 12 months. |
| Target |
| 56925 |
| Q9BS40 |
| ECI; TCI; Latexin; Endogenous carboxypeptidase inhibitor; Protein MUM; Tissue carboxypeptidase inhibitor; LXN |
| Hardly reversible, non-competitive, and potent inhibitor of CPA1, CPA2 and CPA4. May play a role in inflammation. |
| Application Dilution |
| WB |
1:300-5000 |